Table of Contents

company-logo

TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infections; and TMB-380, a neutralizing HIV-1 antibody. The company was incorporated in 2007 and is headquartered in Taipei, Taiwan.

TaiMed Biologics Dividend Announcement

• TaiMed Biologics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on TaiMed Biologics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

TaiMed Biologics Dividend History

TaiMed Biologics Dividend Yield

TaiMed Biologics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing TaiMed Biologics stock? Use our calculator to estimate your expected dividend yield:

TaiMed Biologics Financial Ratios

P/E ratio-160.26
PEG ratio-58.58
P/B ratio5.47
ROE-3.75%
Payout ratio0.00%
Current ratio5.66
Quick ratio4.10
Cash Ratio1.41

TaiMed Biologics Dividend FAQ

Does TaiMed Biologics stock pay dividends?
TaiMed Biologics does not currently pay dividends to its shareholders.
Has TaiMed Biologics ever paid a dividend?
No, TaiMed Biologics has no a history of paying dividends to its shareholders. TaiMed Biologics is not known for its dividend payments.
Why doesn't TaiMed Biologics pay dividends?
There are several potential reasons why TaiMed Biologics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will TaiMed Biologics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While TaiMed Biologics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is TaiMed Biologics a dividend aristocrat?
TaiMed Biologics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is TaiMed Biologics a dividend king?
TaiMed Biologics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is TaiMed Biologics a dividend stock?
No, TaiMed Biologics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy TaiMed Biologics stocks?
To buy TaiMed Biologics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy TaiMed Biologics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.